Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 250 participants.
Also called NCT07806279
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 250 participants
- Sponsor
- Registry
-
NCT07806279 -
2026-527136-13-00
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Sweden
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07806279. Randomized; no masking; primary purpose treatment. Start 2026-10-30 (anticipated); primary completion 2030-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk
- Condition
- Cardiometabolic Syndrome
- Condition
- Obesity and Cardiovascular Risk
- Condition
- Overweight , Obesity
- Intervention (Drug)
- Bupropion 150 mg
- Intervention (Dietary supplement)
- Lyophilized powder from edible mushrooms
- Intervention (Behavioral)
- Lifestyle Management
- Lead sponsor
- Uppsala University
Record details
- Record id
cardio:ct-nct07806279- Content hash
2f384704be4c4b326b850cdb83d21c4195f6353b5dfc09fbc896f911dc187431